Ansamycin: Difference between revisions

4 bytes removed ,  6 years ago
Rifamycins are a subclass of ansamycins with high potency against mycobacterial activitymycobacteria. This resulted in their widewidespread use in the treatment of [[tuberculosis]], [[leprosy]], and AIDS-related mycobacterial infections.<ref>{{cite journal |author=Floss, H. G.; Yu, T. |journal=Curr. Opin. Chem. Biol. |title=Lessons from the rifamycin biosynthetic gene cluster |volume=3 |pages=592 |year=1999 |doi=10.1016/S1367-5931(99)00014-9 |pmid=10508670 |issue=5}}</ref> Since then various analogues have been isolated from other prokaryotes.